HIGHLIGHTS
- who: March and colleagues from the Hospital, China Cleveland State University, United States have published the research: Curative effect of anti-brosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis, in the Journal: (JOURNAL)
SUMMARY
The main pathological features of the liver include progressive, non-suppurative, and destructive intrahepatic cholangitis, leading to fibrosis and eventually cirrhosis (Zhang et_al, 2021; You et_al, 2022; European Association for the Study of the Liver, 2017). Ursodeoxycholic acid (UDCA) is an effective treatment for PBC (You et_al, 2022), and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.